Latest Breaking News On - Why seelos therapeutics shares are diving - Page 1 : comparemela.com

A Department of Defense (DOD) Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members and veterans.

United statesRepublic ofRaj mehraArmy medical departmentJavelin pharmaceuticals inc hospiraA departmentAgency for healthcare researchHealth agency fundedSeelos therapeuticsWhy seelos therapeutics shares are divingMedical departmentJavelin pharmaceuticals incInvestigational new drugMajor depressive disorderKorean warVietnam war